Investigational drug · Phase 2
CM355
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hematoma.
Phase 2Last checked: Nov 19, 2026Latest source record: Jan 27, 2022 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "CM355"
First trial start
2021
Nov 16, 2021
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CM355", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hematoma
Largest trials
Live from ClinicalTrials.gov: studies naming "CM355" as an intervention, largest first.
- A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)Active, not recruiting
Beijing InnoCare Pharma Tech Co., Ltd.Industry
NCT05210868 · 184 participants (planned) · Start Nov 16, 2021 · Primary completion Dec 28, 2026
Drug: CM355 · For: Hematoma
Sites: Beijing, China
- Study of CM355 in Patients With Systemic Lupus ErythematosusActive, not recruiting
Second Xiangya Hospital of Central South UniversityAcademic, hospital or other
NCT07104344 · 5 participants · Start Sep 25, 2025 · Primary completion Jun 15, 2026
Drug: CM355 · For: Systemic Lupus Erythematosus
Sites: Changsha, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.